The Tumor Microenvironment Mediates Immunotherapy Response – Targeted Oncology
Targeted Oncology |
The Tumor Microenvironment Mediates Immunotherapy Response
Targeted Oncology “There is evidence that both acute and chronic inflammation may promote genetic abnormalities and cancer progression, suggesting that modulation of the innate immune system has the potential to impact our approach to cancer immunotherapy,” explained … X4 Pharmaceuticals Presents Clinical Data Demonstrating Immune Activation Through CXCR4 Pathway with X4P-001-IO |
